Efficacy News and Research

RSS

Single dose of malaria monoclonal antibody 77% effective in children, trial in Mali shows

One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country's six-month malaria season, according to the results of a mid-stage clinical trial.

26 Apr 2024

Spain's Secretary of State meets with WHO to discuss global health priorities

WHO welcomed Mr Javier Padilla Bernáldez, Spain's Secretary of State for Health and his delegation on 23 and 24 April 2024 to discuss joint global health priorities.

26 Apr 2024

First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer

The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer.

26 Apr 2024

Exploring the potential of ketogenic diets in managing epilepsy

The mechanisms of action, efficacy, and side effects of ketogenic diet (KD) variations in epileptic patients.

26 Apr 2024

Cinnamon, curcumin, and resveratrol show promise in diabetes inflammation fight

Researchers reviewed the impact of cinnamon, curcumin, and resveratrol on oxidative stress and inflammation in type 2 diabetes patients, highlighting their potential to improve metabolic regulation and reduce complications.

26 Apr 2024

AI in healthcare shows promise in trials but needs real-world testing to ensure effectiveness

A comprehensive study published in The Lancet Digital Health analyzed the efficacy and challenges of AI in clinical settings, revealing a critical need for real-world testing and diverse research methodologies to ensure AI's reliable integration into healthcare.

25 Apr 2024

MIT study reveals circadian impact on drug metabolism in engineered livers

Giving drugs at different times of day could significantly affect how they are metabolized in the liver, according to a new study from MIT.

25 Apr 2024

Insilico Medicine's AI-designed drug ISM3412 receives FDA IND approval

Clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine announces that it has received approval from the U.S. Food and Drug Administration for its Investigational New Drug application for ISM3412, a small molecule inhibitor of MAT2A for the potential treatment of MTAP deleted cancers designed with Insilico's generative AI platform.

25 Apr 2024

Study illuminates the interplay between health care technologies and essence of compassionate care

Cross Country Healthcare, Inc., a pioneering force in tech-driven workforce solutions and advisory services, in collaboration with Florida Atlantic University's Christine E. Lynn College of Nursing, released its latest research findings in the fourth annual installment of the Future of Nursing Survey: "Embracing Technology While Preserving Humanity."

25 Apr 2024

DELiVR's virtual reality training speeds up cell detection in complex brain datasets

Efficient neuronal activity detection in brain imaging.

25 Apr 2024

Mandatory reporting laws meant to protect children get another look

More than 60 years ago, policymakers in Colorado embraced the idea that early intervention could prevent child abuse and save lives.

25 Apr 2024

Therapeutic potential of human umbilical cord-derived mesenchymal stem cells in Crohn’s disease

Whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) could heal luminal ulcers in Crohn’s disease.

25 Apr 2024

New system personalizes chemotherapy doses for cancer patients

When cancer patients undergo chemotherapy, the dose of most drugs is calculated based on the patient's body surface area. This is estimated by plugging the patient's height and weight into an equation, dating to 1916, that was formulated from data on just nine patients.

24 Apr 2024

Research reveals potential target for enfortumab vedotin therapy in urothelial carcinoma

Under the leadership of PD Dr. Niklas Klümper, Assistant Physician at the Department of Urology at the University Hospital Bonn (UKB) and Clinician Scientist of the BMBF-funded ACCENT program and PD Dr. Markus Eckstein, senior physician at the Institute of Pathology at the Uniklinikum Erlangen of the Friedrich-Alexander-University Erlangen-Nürnberg (FAU), an interdisciplinary research team has published new findings that indicate which patients with advanced urothelial carcinoma could benefit in particular from the new targeted therapy with the antibody-drug conjugate enfortumab vedotin.

24 Apr 2024

CASGEVY gene therapy eliminates vaso-occlusive crises in sickle cell patients

In a landmark study, an international consortium led by researchers at Children's Hospital of Philadelphia (CHOP) published the final results of a key clinical trial of the gene therapy CASGEVY (exagamglogene autotemcel) for the treatment of sickle cell disease in patients 12 years and older with recurrent vaso-occlusive crises (VOCs).

24 Apr 2024

New sustainable diagnostic approach offers precision cancer testing with minimal environmental impact

Accurate and cost-effective cancer detection.

24 Apr 2024

Repurposed nasal antibiotic neomycin shows promise in preventing and treating respiratory viral infections

Intranasal administration of neomycin sulfate in murine models shows promise as a prophylactic and therapeutic agent against respiratory viruses like influenza A and SARS-CoV-2 by inducing interferon-stimulated gene (ISG) expression, independent of microbiota and interferon activation.

24 Apr 2024

Research highlights best window for paxlovid administration in COVID-19 patients

1
2
3
4
...
1183
Next

Efficacy News and Research

Single dose of malaria monoclonal antibody 77% effective in children, trial in Mali shows

Spain's Secretary of State meets with WHO to discuss global health priorities

First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer

Exploring the potential of ketogenic diets in managing epilepsy

Cinnamon, curcumin, and resveratrol show promise in diabetes inflammation fight

AI in healthcare shows promise in trials but needs real-world testing to ensure effectiveness

MIT study reveals circadian impact on drug metabolism in engineered livers

Insilico Medicine's AI-designed drug ISM3412 receives FDA IND approval

Study illuminates the interplay between health care technologies and essence of compassionate care

DELiVR's virtual reality training speeds up cell detection in complex brain datasets

Mandatory reporting laws meant to protect children get another look

Therapeutic potential of human umbilical cord-derived mesenchymal stem cells in Crohn’s disease

New system personalizes chemotherapy doses for cancer patients

Research reveals potential target for enfortumab vedotin therapy in urothelial carcinoma

CASGEVY gene therapy eliminates vaso-occlusive crises in sickle cell patients

New sustainable diagnostic approach offers precision cancer testing with minimal environmental impact

Repurposed nasal antibiotic neomycin shows promise in preventing and treating respiratory viral infections

Research highlights best window for paxlovid administration in COVID-19 patients

Investigating the efficacy and safety of existing drugs in patients with rare immune diseases

Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News